These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 10197621
1. Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Vrouenraets MB, Visser GW, Stewart FA, Stigter M, Oppelaar H, Postmus PE, Snow GB, van Dongen GA. Cancer Res; 1999 Apr 01; 59(7):1505-13. PubMed ID: 10197621 [Abstract] [Full Text] [Related]
2. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. Vrouenraets MB, Visser GW, Stigter M, Oppelaar H, Snow GB, van Dongen GA. Cancer Res; 2001 Mar 01; 61(5):1970-5. PubMed ID: 11280754 [Abstract] [Full Text] [Related]
3. Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro. Vrouenraets MB, Visser GW, Stigter M, Oppelaar H, Snow GB, van Dongen GA. Int J Cancer; 2002 Apr 10; 98(5):793-8. PubMed ID: 11920653 [Abstract] [Full Text] [Related]
8. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Rovers JP, Saarnak AE, Molina A, Schuitmaker JJ, Sterenborg HJ, Terpstra OT. Br J Cancer; 1999 Oct 10; 81(4):600-8. PubMed ID: 10574244 [Abstract] [Full Text] [Related]
10. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men. Triesscheijn M, Ruevekamp M, Out R, Van Berkel TJ, Schellens J, Baas P, Stewart FA. Cancer Chemother Pharmacol; 2007 Jun 10; 60(1):113-22. PubMed ID: 17009028 [Abstract] [Full Text] [Related]
11. Photodynamic therapy as novel nephron sparing treatment option for small renal masses. Kroeze SG, Grimbergen MC, Rehmann H, Bosch JL, Jans JJ. J Urol; 2012 Jan 10; 187(1):289-95. PubMed ID: 22099991 [Abstract] [Full Text] [Related]
13. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response. Triesscheijn M, Ruevekamp M, Aalders M, Baas P, Stewart FA. Photochem Photobiol; 2005 Jan 10; 81(5):1161-7. PubMed ID: 15934792 [Abstract] [Full Text] [Related]
17. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts. Safavy A, Khazaeli MB, Safavy K, Mayo MS, Buchsbaum DJ. Clin Cancer Res; 1999 Oct 10; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333 [Abstract] [Full Text] [Related]
18. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. Lassalle HP, Dumas D, Gräfe S, D'Hallewin MA, Guillemin F, Bezdetnaya L. J Control Release; 2009 Mar 04; 134(2):118-24. PubMed ID: 19100297 [Abstract] [Full Text] [Related]
19. Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin. Yankovsky I, Bastien E, Yakavets I, Khludeyev I, Lassalle HP, Gräfe S, Bezdetnaya L, Zorin V. Eur J Pharm Sci; 2016 Aug 25; 91():172-82. PubMed ID: 27320407 [Abstract] [Full Text] [Related]